← All diseases Liver, kidneys and digestion

Chronic kidney disease, stage 4-5

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level evidence only (171)Meta-analysis (31)Treatment guideline (9)Randomized controlled trial (79)Systematic review (35)Phase 3 study (17)Clinical trial (146)Review article (468)Early-stage study (phase 1 or 2) (13)Case description (154)Laboratory or animal research (105)Commentary or editorial (59)Retracted Publication (4) Studies currently recruiting participants only (55)

Filter

Publications and studies (2797)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicine as a therapeutic option for cerebral small vessel disease: treatment outcomes and potential mechanisms. (2026/08/10) ♡
• Network pharmacology and experimental verification reveal the mechanism of hederagenin in suppressing podocyte injury in focal segmental glomerular sclerosis. (2026/08/10) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vitamin D status and supplementation in left ventricular remodeling in chronic kidney disease: A systematic review and meta-analysis. (2026/08/10) ♡
• Osteoporotic fracture, diagnostic activity, and treatment in patients with gout. (2026/08/10) ♡
• Correction to: Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease. (2026/08/10) ♡
• Exosomes in kidney disease: From Pathophysiology to Diagnostic and Therapeutic Tools. (2026/08/10) ♡
• Dynamic patterns of thyroid hormones and incident chronic kidney disease: evidence from 18 years of follow-up in the Tehran Thyroid Study. (2026/08/10) ♡
• Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study. (2026/08/10) ♡
• Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases. (2026/08/10) ♡
• Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries. (2026/08/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gallstones and acute cholecystitis in CKD and dialysis: an underrecognized biliary burden in nephrology. (2026/08/10) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Monitoring vascular changes in renal fibrosis in mice using multimodal optical and ultrasonic imaging. (2026/08/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ultrasound-Guided Intertransverse Process and Deep Rectus Sheath Blocks for Emergency Laparoscopic Cholecystectomy in a High-Risk Elderly Patient: A Case Report. (2026/08/09) ♡
• Prevalence, Incidence and Mortality of Chronic Kidney Disease in Type 1 and Type 2 Diabetes-A Nationwide Danish Register-Based Cohort Study. (2026/08/09) ♡
• Association between glomerular filtration rate and comprehensive geriatric assessment parameters in older adults. (2026/08/09) ♡
• Incident chronic kidney disease risk and the predictive value of the uric acid-to-HDL ratio in lean and non-lean MASLD: a prospective cohort and multi-omics study. (2026/08/09) ♡
• Type 2 Myocardial Infarction in Patients With Cardiorenal Vulnerability: Mechanisms, Diagnostic Challenges, and a Proposed Clinical Pathway. (2026/08/08) ♡
• Association of the combined triglyceride-glucose and frailty index with chronic kidney disease: evidence from two national cohort studies. (2026/08/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation. (2026/08/08) ♡
• The AKI-CKD Continuum: Mechanisms and Therapeutic Interventions. (2026/08/08) ♡
• Association Between Dietary Magnesium Intake and All-Cause Mortality in Patients with Chronic Kidney Disease: Insights from NHANES 1999-2018. (2026/08/08) ♡
• Long-term Outcomes of Renal Function Following CTO PCI: Insights on Contrast Exposure. (2026/08/08) ♡
• Machine learning-assisted prediction of 5-year mortality in chronic kidney disease: the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Contemporary medical therapy for heart failure with mildly reduced or preserved ejection fraction. (2026/08/07) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease. (2026/08/07) ♡
• Impact of race on comorbidity burden and clinical outcomes among Southeast Asians with lupus nephritis: a single-center retrospective study. (2026/08/07) ♡
• Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiovascular, and Kidney Disease: Triple Challenges. (2026/08/07) ♡
• Urinary Dickkopf-3 as a biomarker for kidney-function decline: a systematic review and meta-analysis. (2026/08/07) ♡
• CKD-associated osteoporosis in patients with CKD G4-5D: a pragmatic treatment approach. (2026/08/07) ♡
• Proteasome-dependent cytoskeleton disruption during Leptospira interrogans infection induces aberrant collective cell migration. (2026/08/07) ♡
• Burden of chronic kidney disease and its attributable risk factors in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease study 2021. (2026/08/07) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A Mobile-Based Mindfulness Intervention for Reducing Demoralization in Patients on Maintenance Hemodialysis: Randomized Controlled Trial. (2026/08/07) ♡
• Adoption effect of seamless care in the nursing of patients with chronic renal insufficiency. (2026/08/07) ♡
• Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis. (2026/08/07) ♡
• Prior Endovascular Failure Patterns Identify a High-Risk Phenotype for Infrainguinal Bypass in Chronic Limb-Threatening Ischemia. (2026/08/07) ♡
• The association between atherogenic index of plasma, cumulative atherogenic index of plasma and type 2 diabetes mellitus with chronic kidney disease among older Chinese adults: Findings from the CHARLS study. (2026/08/07) ♡
• Sepsis and Infectious Outcomes for GLP-r Agonists in CKD plus Type 2 Diabetes. (2026/08/07) ♡
• Association of anemia with diabetic kidney disease in adults with type 2 diabetes: A cross-sectional NHANES study and 2-sample Mendelian randomization analysis. (2026/08/07) ♡
• Simultaneous Heart-Kidney Transplantation for Ebstein's Anomaly: A Viable Treatment Option in Latin America. (2026/08/07) ♡
• HDL-associated proteins affecting CVD and systemic inflammation. (2026/08/06) ♡
• Childhood isolated systolic hypertension is not benign: adult hypertension and cardiovascular remodeling. (2026/08/06) ♡
• Comparative Efficacy and Safety of Antihypertensive Strategies in Diabetic Kidney Disease: Protocol for an Update of a Systematic Review and Component Network Meta-Analysis. (2026/08/06) ♡
• Diet and Atherosclerosis Prevention: Rethinking the Significance of "The Japan Diet". (2026/08/06) ♡
• A Study of Anemia in the Geriatric Population at a Tertiary Care Center. (2026/08/06) ♡
• Effect of Dietary Interventions on Phase Angle in Patients with Chronic Kidney Disease Undergoing Dialysis: A Systematic Review and Meta-Analysis. (2026/08/06) ♡
• Volatilomic analysis of blood and urine by headspace solid-phase microextraction gas chromatography/mass spectrometry for complementary assessment of chronic kidney disease. (2026/08/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Suicide by exsanguination from a puncture wound to a haemodialysis arteriovenous fistula: a forensic case report with forensic implications. (2026/08/05) ♡
• Associations Between the Inflammation Burden Index and Cardiovascular-Kidney-Metabolic Syndrome: A Cross-Sectional Study Based upon the NHANES Database. (2026/08/05) ♡
• Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK Study. (2026/08/05) ♡
• A Cross-Sectional Analytical Study: Prevalence and Clinical Profile of Metabolic Syndrome Among Middle Eastern, Mainly Jordanians, Cohort Presented with Atherosclerotic Cardiovascular Disease. (2026/08/05) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.